What is the most effective education strategy to ensure a patient with chronic obstructive pulmonary disease (COPD) uses a new inhaler with a combination of a long-acting beta2 agonist (LABA) and long-acting muscarinic antagonist (LAMA) correctly?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Teach-Back Method is Most Effective for Ensuring Proper Inhaler Technique in COPD Patients

Using the teach-back method by asking the patient to demonstrate the inhaler technique is the most effective education strategy to ensure proper use of a new LABA/LAMA combination inhaler in COPD patients.

Evidence for Teach-Back Method

The Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines specifically highlight the teach-back approach as an effective method for improving inhaler technique in COPD patients. Evidence shows that education improves inhalation technique in many patients, especially when the "teach-back" approach is implemented 1.

A randomized controlled trial comparing different educational strategies found that teach-to-goal (which incorporates teach-back with repeated demonstrations) was significantly more effective than brief intervention (simple verbal and written instructions) for improving inhaler technique:

  • Teach-to-goal reduced metered-dose inhaler misuse to 12.5% compared to 46% with brief intervention (p=0.01) 2
  • Patients receiving teach-back had significantly fewer 30-day acute health-related events (1 vs 8, p=0.02) 2

Why Teach-Back Works Better Than Alternatives

Compared to Written Instructions (Leaflets)

  • Many COPD patients overestimate their inhaler technique ability, with studies showing that while 70% of patients report confidence in their MDI technique, 62% actually misuse their inhalers 2
  • Simply providing written materials doesn't address this confidence-competence gap
  • Written materials alone don't provide feedback on technique errors

Compared to Video Demonstrations

  • Videos provide standardized information but lack personalized feedback
  • Cannot identify or correct individual patient errors in real-time
  • No opportunity to assess comprehension

Compared to Web-Based Training

  • While web-based training can be useful as a supplement, it doesn't provide immediate feedback from healthcare professionals
  • May present accessibility challenges for some COPD patients, particularly older adults

Practical Implementation of Teach-Back Method

  1. Demonstrate first: Show the patient the correct technique step-by-step
  2. Have patient demonstrate: Ask the patient to show you how they would use the inhaler
  3. Provide feedback: Correct any errors in technique
  4. Repeat demonstration: Have the patient demonstrate again until technique is correct
  5. Reassess at follow-up visits: Inhaler technique should be regularly checked at each visit

Common Pitfalls and How to Avoid Them

  • Poor coordination: Many patients struggle with coordinating activation and inhalation with LABA/LAMA inhalers
  • Inadequate breath-hold: Patients often don't hold their breath long enough after inhalation
  • Incorrect inhalation speed: Patients may inhale too quickly or too slowly depending on the device
  • Multiple device confusion: Using different types of inhalers can lead to technique errors

Special Considerations for LABA/LAMA Combination Inhalers

LABA/LAMA combinations are delivered through various inhaler devices (DPIs, MDIs, SMIs), each requiring specific techniques:

  • Dry powder inhalers (DPIs): Require adequate inspiratory flow
  • Metered-dose inhalers (MDIs): Require good hand-breath coordination
  • Soft mist inhalers (SMIs): Require proper assembly and priming

The Canadian Thoracic Society emphasizes the importance of "optimizing inhaler device technique and [re-]review" as part of self-management education for COPD patients 1.

Conclusion

For a COPD patient starting a new LABA/LAMA combination inhaler with a history of poor technique, the teach-back method is clearly superior to other educational approaches. This method allows healthcare providers to identify and correct technique errors in real-time, ensuring the patient can properly use their inhaler before leaving the clinical encounter, which ultimately improves medication delivery, symptom control, and reduces the risk of exacerbations.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the most effective education strategy to ensure a patient with chronic obstructive pulmonary disease (COPD) uses a new inhaler with a combination of a long-acting beta2 agonist (LABA) and long-acting muscarinic antagonist (LAMA) correctly?
What is the best treatment regimen for Chronic Obstructive Pulmonary Disease (COPD)?
What are the next steps for a patient with chronic obstructive pulmonary disease (COPD) experiencing multiple exacerbations despite optimized inhaler therapy, including a long-acting beta-agonist (LABA) and a long-acting muscarinic antagonist (LAMA)?
Can a Long-Acting Muscarinic Antagonist (LAMA) and/or Inhaled Corticosteroid (ICS) be used alongside theophylline?
What is the most appropriate next step in management for a patient with GOLD (Global Initiative for Chronic Obstructive Lung Disease) stage three COPD (Chronic Obstructive Pulmonary Disease) experiencing frequent exacerbations despite being on a LABA (Long-Acting Beta Agonist)?
Which patient with chronic obstructive pulmonary disease (COPD) has the highest risk of developing pneumonia when receiving inhaled corticosteroid (ICS) therapy?
Should an inhaled corticosteroid (ICS) be started in a patient with chronic obstructive pulmonary disease (COPD) and a history of exacerbations, despite adherence to formoterol (a long-acting beta2-adrenergic receptor agonist (LABA))/aclidinium (a long-acting muscarinic antagonist (LAMA)), to reduce the risk of future exacerbations?
What is the best management approach for congestive heart failure (CHF) with low lung volumes due to bibasilar atelectasis and scant effusion on chest x-ray?
Should procalcitonin levels be used to guide the duration of azithromycin (macrolide antibiotic) therapy in a patient with an acute chronic obstructive pulmonary disease (COPD) exacerbation?
What is the treatment approach for symptoms post-cholecystectomy?
What is the recommended treatment for community-acquired pneumonia (CAP) in adults?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.